| (KRW) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 44.28B | — |
| Operating expense | — | — |
| Net income | -19.23B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 009420.KS returned +110.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +36.7% |
| 1 year | +110.2% |
| 5 years | +150.2% |
| 10 years | +198.3% |
| All-time high | ₩62,500 (May 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₩1,000 in 009420.KS would be worth today ›No. Hanall Biopharma Co., Ltd. has not paid a dividend in the past 12 months.
Hanall Biopharma Co., Ltd. is part of the Healthcare sector.
Hanall Biopharma Co., Ltd. has a market cap of 3.04T KRW, based on the latest quote.
